Data / Form D filings / Pacylex Pharmaceuticals Inc.
Pacylex Pharmaceuticals Inc.: Form D filings
Pacylex Pharmaceuticals Inc., a pharmaceuticals company in Calgary, Alberta, Canada, filed 2 Form D notices with the SEC between 2021 and 2024. The latest, on April 4, 2024, reports $75,000 sold of a $75,000 offering to 3 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 400 3rd Avenue SW, Suite 3700, Calgary, Alberta, Canada, T2P 4
- Phone
- (780) 264-4295
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Canada (Federal Level)
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1866841
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 4, 2024 | New notice | $75,000 | $75,000 | 3 | Mar 21, 2024 | sec.gov | |
| Jun 14, 2021 | New notice | $7,184,198 | $7,184,198 | 6 | May 28, 2021 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ajit G. Gill | Director | |
| Michael Weickert | Director, Executive Officer | |
| Nola G. Masterson | Director | |
| Luc G. Berthiaume | Director | |
| John G. Mackey | Director | |
| Ryan G. Heit | Executive Officer | |
| Cindy Jacobs | Director | |
| Mark Huson | Director |
Every Form D from the week of Apr 1, 2024 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Pacylex Pharmaceuticals Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.